Hermela Shimelis, Ph.D.
Affiliations: | 2013 | Toxicology | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Molecular Biology, Cell Biology, BiochemistryGoogle:
"Hermela Shimelis"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Yun Qiu | grad student | 2013 | University of Maryland Medical School | |
| (Bi-directional regulation between RNF6 and AKT: Potential mediators of prostate cancer progression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hu C, Belur Nagaraj A, Shimelis H, et al. (2023) Functional and clinical characterization of variants of uncertain significance identifies a hotspot for inactivating missense variants in RAD51C. Cancer Research |
| Deshmukh D, Xu J, Yang X, et al. (2022) Regulation of p27 (Kip1) by Ubiquitin E3 Ligase RNF6. Pharmaceutics. 14 |
| Minguillón J, Ramírez MJ, Rovirosa L, et al. (2022) CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival. Cancers. 14 |
| Hu C, Polley EC, Yadav S, et al. (2020) The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort. Journal of the National Cancer Institute |
| Li H, LaDuca H, Pesaran T, et al. (2019) Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort. Genetics in Medicine : Official Journal of the American College of Medical Genetics |
| Yadav S, LaDuca H, Polley E, et al. (2019) Racial and ethnic differences in the results of multigene panel testing of inherited cancer predisposition genes in breast cancer patients. Journal of Clinical Oncology. 37: 1514-1514 |
| Hu C, LaDuca H, Shimelis H, et al. (2018) Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes. Jco Precision Oncology. 2 |
| Lee K, Seifert BA, Shimelis H, et al. (2018) Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels. Genetics in Medicine : Official Journal of the American College of Medical Genetics |
| Shimelis H, LaDuca H, Hu C, et al. (2018) Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing. Journal of the National Cancer Institute |
| Antwi SO, Fagan SE, Chaffee KG, et al. (2018) Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status. Journal of the National Cancer Institute |